New Jersey’s Department of Environmental Protection (DEP) has filed a lawsuit against Pfizer, Johnson & Johnson, Honeywell and several real estate companies, claiming there is toxic waste on an old pharmaceutical plant site, contaminating the groundwater.
The plant, located in Morris Plains, was operational from the 1950s to the 1980s under Warner-Lambert, which Pfizer acquired in 2000. The state claimed the other defendants were “knowing purchasers” of parts of the site. Under New Jersey’s Spill Act, passed in 1976, these companies can be held liable for cleanup if they bought the land with knowledge of the contamination.
The state is requesting financial compensation for past and future cleanup of the site. There was no specific number stated. The claim alleges that the plant discharged trichloroethylene (TCE), a carcinogen, as well as other hazardous chemicals, contaminating the groundwater.
In 2012, the site was designated as a classification exception area (CEA), signifying that state groundwater quality standards were not being met and barring the water for drinking or other use. When the site was established as a CEA, the groundwater had a concentration of TCE equal to 5.95 micrograms per liter. The state’s standard is 1 microgram per liter.
Pfizer spokesman Steven Danehy said in a statement that the company had “a long-standing commitment to protecting the environment,” and that the company was “looking forward” to resolving the allegations.
Two lawsuit veterans
As this arises, Pfizer is currently engaged in two other lawsuits. One by the Texas Attorney General Ken Paxton for misleading the public about the efficacy of the COVID vaccine, and the other a multidistrict litigation for failing to warn about the link between Depo-Provera, a contraceptive, and brain tumors.

NJ Pharma lawsuit settlements
This is not the first time New Jersey has sued big pharmaceutical companies. In 2023, the state reached a $393 million settlement with Solvay for PFAS contamination. This summer, NJ made a settlement with DuPont for $2 billion, also for PFAS, the state’s largest ever settlement for ‘forever chemicals’. In May, 3M agreed to pay up to $450 million to the state for contamination from PFAS, which had been occurring for decades. New Jersey is a veteran in this space, and the most recent suit could be another big payout for the state.
As the plant is no longer operational, the impact of the suit on Pfizer will likely be minimal. It will likely be a few years before any kind of result or settlement is reached.
Filed Under: Biologics



